Paramita Kundu

Bengaluru, KA, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Pan-cancer drivers of metastasis.

Pan-cancer drivers of metastasis.

Journal: Molecular cancer
Published: June 30, 2024

DNA Methylation in Recurrent Glioblastomas: Increased TEM8 Expression Activates the Src/PI3K/AKT/GSK-3β/B-Catenin Pathway.

DNA Methylation in Recurrent Glioblastomas: Increased TEM8 Expression Activates the Src/PI3K/AKT/GSK-3β/B-Catenin Pathway.

Journal: Cancer genomics & proteomics
Published: April 01, 2024

Cobalt(III) Complexes for Light-Activated Delivery of Acetylacetonate-BODIPY, Cellular Imaging, and Photodynamic Therapy.

Cobalt(III) Complexes for Light-Activated Delivery of Acetylacetonate-BODIPY, Cellular Imaging, and Photodynamic Therapy.

Journal: Inorganic chemistry
Published: April 26, 2022

BODIPY-Tagged Platinum(II) Curcumin Complexes for Endoplasmic Reticulum-Targeted Red Light PDT.

BODIPY-Tagged Platinum(II) Curcumin Complexes for Endoplasmic Reticulum-Targeted Red Light PDT.

Journal: Inorganic chemistry
Published: January 06, 2022

BODIPY-Ruthenium(II) Bis-Terpyridine Complexes for Cellular Imaging and Type-I/-II Photodynamic Therapy.

BODIPY-Ruthenium(II) Bis-Terpyridine Complexes for Cellular Imaging and Type-I/-II Photodynamic Therapy.

Journal: Inorganic chemistry
Published: October 21, 2021

Maloplatin-B, a Cisplatin-Based BODIPY-Tagged Mito-Specific "Chemo-PDT" Agent Active in Red Light.

Maloplatin-B, a Cisplatin-Based BODIPY-Tagged Mito-Specific "Chemo-PDT" Agent Active in Red Light.

Journal: Inorganic chemistry
Published: April 12, 2021

Genome-wide DNA methylation changes in oral submucous fibrosis.

Genome-wide DNA methylation changes in oral submucous fibrosis.

Journal: Oral diseases
Published: November 06, 2020

Low mitochondrial DNA copy number is associated with poor prognosis and treatment resistance in glioblastoma.

Low mitochondrial DNA copy number is associated with poor prognosis and treatment resistance in glioblastoma.

Journal: Mitochondrion
Published: February 11, 2020

Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.

Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.

Journal: Inorganic chemistry
Published: December 12, 2019

Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma.

Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma.

Journal: Scientific reports
Published: January 19, 2018
Showing 1-10 of 10

Last Updated: 09/26/2026